Nelarabine

Back to search

Molecule Structure

Scientific Name

Nelarabine

Description of the Drug

Nelarabine is a purine nucleoside analog and antineoplastic agent used for the treatment of with acute T-cell lymphoblastic leukemia and T-cell lymphoblastic lymphoma with inadequate clinical response to prior chemotherapeutic treatments.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01280

Brand Name(s)

Arranon, Atriance

Company Owner(s)

Zydus Pharmaceuticals Usa Inc, Novartis Pharmaceuticals Corp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
DNA NUCLEIC-ACID INHIBITOR CHEMBL2311221

Unichem Links

SureChEMBL SCHEMBL18820
PharmGKB PA164752425
Human Metabolome Database HMDB0015401
DrugBank DB01280
PubChem: Thomson Pharma 14775959 14922755
PubChem 3011155
LINCS LSM-45931
Nikkaji J679.698B
BindingDB 50247985
EPA CompTox Dashboard DTXSID6046842
DrugCentral 1892
ChemicalBook CB01011878
Guide to Pharmacology 7090
rxnorm ARRANON NELARABINE
PubChem: Drugs of the Future 12015013
ChEBI 63612
ZINC ZINC000003823492